Patient P-02550

Synthetic patientMETA-24 · Day 169 · 45–54 · F · baseline S01Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Favorable

GI state

Improving

Inflammatory state

Improving

Nutritional resilience

Improving

Discontinuation risk

19%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S01

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Inflammatory activity-7
Treatment adherence-6
GI instability-5
Nutritional resilience+5

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

30 min

improving · +3.8 vs previous 14 d

Sleep duration

Wearable

6.4 h

stable · +0.0 vs previous 14 d

Energy level

Daily log

6.2/10

improving · +0.5 vs previous 14 d

Steps

Wearable

3,103

improving · +458 vs previous 14 d

GI burden

Companion

20.6/100

improving · -3.4 vs previous 14 d

Adherence

Companion

86.6 %

stable · -1.0 vs previous 14 d

Sleep quality

Wearable

39.4/100

stable · +0.8 vs previous 14 d

Glucose, CGM daily mean

CGM

127 mg/dL

stable · -2.0 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 77 from the failing basin, 10 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Protein (supports)
perturbation · steering +7
Daily walks resumed
perturbation · steering +3.3
Protein
supporter · GI -3.7 next day

Main detractors to watch

Rapid metabolizer
hidden · steering -8
Bacteroides fragilis elevated
hidden · steering -7.4
Low-HRV stretch
perturbation · steering -2.7
Dietary drift
perturbation · steering -2.6

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-3.7supporter · 95%
Ultra-processed food
+1.5no signal · 47%
Caffeine
+1.3no signal · 27%
Histamine load
-1no signal · 32%
Simple carbohydrates
+0.9no signal · 22%
Alcohol
+0.9no signal · 24%
Dietary fat load
-0.2no signal · 15%
Insoluble fibre
-0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↓40
- Wearable3,103 steps/day
- WearableShort sleep window
Inflammatory signalling ↓35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 33 ms, trending down
Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted

DNA

Fictional pharmacogenomic panel

CYP2D6 Rapid metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 4.1 · butyrate capacity 57/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 37 ms
Sleep: 6.5 h
Steps: 3,413
Resting HR: 61 bpm

Daily log: GI score 21, nutritional resilience 63, adherence 87.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02555	33%	S01	AD-05	no change	79
P-02483	45%	S06	BR-03	no change	64
P-02282	33%	S01	BR-03	no change	88
P-02354	47%	S01	CR-01	improved	78
P-02518	48%	S17	DT-01	improved	68
P-02491	46%	S09	DT-01	no change	65
P-02462	45%	S12	DT-01	improved	65
P-02126	37%	S16	DT-01	improved	59
P-02235	36%	S14	DT-01	improved	50
P-02330	35%	S15	DT-01	no change	57
P-02339	35%	S03	DT-01	improved	50
P-02218	34%	S01	DT-01	improved	61